Chronic Hypertension Before Pregnancy Tied to 30% Higher Risk of Critical Congenital Heart Defects

The observational analysis of national birth records showed chronic hypertension prevalence rising 48% to 13.9% of pregnancies by 2024, while critical congenital heart disease rates climbed 10% to 6.4 per 10,000 births. Chronic hypertension carried the strongest signal at 30% higher risk; preexisting diabetes showed 48% elevated odds; gestational hypertension added only 8%. Eclampsia showed no significant link. These figures come from unadjusted registry data presented at the American Heart Association Scientific Sessions 2026.

Rising rates of both hypertension and diabetes mirror broader trends in reproductive-age women, including delayed childbearing and higher baseline obesity. Related observational cohorts in Circulation and JAMA Pediatrics have reported similar dose-response patterns between preconception blood pressure and outflow-tract defects, suggesting shared pathways of placental vascular maldevelopment rather than solely acute peripartum effects.

The study cannot establish causation or isolate medication effects from the underlying conditions. Next steps require prospective cohorts with serial echocardiography, medication reconciliation, and glycemic control metrics to test whether tighter preconception targets reduce incidence below the current 6.4 per 10,000 baseline.